Cryo-Cell International, Inc. (CCEL): Valuation
TTM figures as of May 31, 2026
Cryo-Cell International, Inc. trades at a 17.22% free-cash-flow yield. That FCF yield is higher than 95% of its own month-end history back to 2011.
Earnings yield -6.95%. Shareholder yield 0.23%. Piotroski F-score 6 of 9. Net debt $5.3M.
184 month-end valuation observations are on file, starting May 2011.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is CCEL cheap versus its own history?
Cryo-Cell International, Inc. trades at a 17.22% free-cash-flow yield. That FCF yield is higher than 95% of its own month-end history back to 2011.
What is CCEL's free-cash-flow yield?
Cryo-Cell International, Inc. currently yields 17.22% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.